However, of the 6 patients with both CASPR2 and LGI1 antibodies, 3 (50%) had thymoma and 1 had developed prostate cancer; 1 had mild disease that responded to carbamazepine alone. The gene discussed is LGI1; the disease is prostate carcinoma.